Weight-Loss drug wegovy could boost heart ablation success
Disease control
Not yet recruiting
This study tests whether taking semaglutide (Wegovy) for at least three months before a first-time atrial fibrillation ablation can improve heart rhythm outcomes. 200 overweight or obese adults scheduled for ablation will be randomly assigned to either standard care or semaglutid…
Phase: PHASE4 • Sponsor: Emma Svennberg • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC